Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trials.

TitleNivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trials.
Publication TypeJournal Article
X
Enter your linkblue username.
Enter your linkblue password.
Secure Login

This login is SSL protected

Loading